Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
Read More

Reported Late Thursday, Geron Corporation Announces Pricing Of $198M Upsized Public Offering Of 55,876,297 Shares Of Common Stock At A Price Of $2.45/Share

Geron Corporation (NASDAQ:GERN), a late-stage clinical biopharmaceutical company, today announced the pricing of an upsized underwritten public offering consisting of 55,876,297 shares of its common stock at a public offering price of $2.45 per share and pre-funded warrants to purchase 25,000,000 shares of its com

GERN